Salmonella fimbriae as novel vectors to express foreign gene fragment

Chinese Journal of Microbiology and Immunology

Volumn 26, Issue 11, 2006, Pages 974-978

  Bu, Xiao Xia ^a   White, Aaron ^b   Wang, Ling ^b   Liu, Shu Lin ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b NONE

Author keywords

Expression of foreign genes; Gene replacement; Plasmid pHSG415; Salmonella; Thin aggregative fimbriae

Indexed keywords

BACTERIAL DNA; PLASMID VECTOR;

AGFA GENE; ARTICLE; BACTERIAL GENE; DNA SEQUENCE; ELECTROPORATION; FIMBRIA; GENE EXPRESSION; GENE INSERTION; GENE REPLACEMENT THERAPY; GENE TARGETING; GENETIC ANALYSIS; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; SALMONELLA TYPHIMURIUM; WESTERN BLOTTING;

EID: 33847047486     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hormaeche CE. Live attenuated Salmonella vaccines and their potential as oral combined vaccines carrying heterologous antigens. J Immunol Methods, 1991, 142(1): 113-120.
2. Hashimoto-Gotoh T, Franklin FC, Nordheim A, et al. Specific-purpose plasmid cloning vectors. I. Low copy number, temperature-sensitive, mobilization-defective pSC101-derived containment vectors. Gene, 1981, 16(1-3): 227-235.
3. Horton RM, Hunt HD, Ho SN, et al. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene, 1989, 77(1): 61-68.
4. Collinson SK, Emody L, Muller KH, et al. Purification and characterization of thin, aggregative fimbriae from Salmonella enteritidis. J Bacteriol, 1991, 173(15): 4773-4781.
5. White AP, Collinson SK, Banser PA, et al. Salmonella enteritidis fimbriae displaying a heterologous epitope reveal a uniquely flexible structure and assembly mechanism. J Mol Biol, 2000, 296(2): 361-372.
6. White AP, Collinson SK, Burian J, et al. High efficiency gene replacement in Salmonella enteritidis: chimeric fimbrins containing a T-cell epitope from Leishmania major. Vaccine, 1999, 17(17): 2150-2161.
7. Mascola JR, Louder MK, VanCott TC, et al. Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12. J Virol, 1997, 71(10): 7198-7206.
8. Purtscher M, Trkola A, Grassauer A, et al. Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5. Aids, 1996, 10(6): 587-593.
9. Purtscher M, Trkola A, Gruber G, et al. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses, 1994, 10(12): 1651-1658.
10. Xu W, Smith-Franklin BA, Li PL, et al. Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B. J Hum Virol, 2001, 4(2): 55-61.
11. Muster T, Steindl F, Purtscher M, et al. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol, 1993, 67(11): 6642-6647.
12. Caulcott CA, Dunn A, Robertson HA, et al. Investigation of the effect of growth environment on the stability of low-copy-number plasmids in Escherichia coli. J Gen Microbiol, 1987, 133(7): 1881-1889.
13. Ingmer H, Cohen SN. The pSC101 par locus alters protein-DNA interactions in vivo at the plasmid replication origin. J Bacteriol, 1993, 175(18): 6046-6048.
14. Manen D, Goebel T, Caro L. The par region of pSC101 affects plasmid copy number as well as stability. Mol Microbiol, 1990, 4(11): 1839-1846.
15. Wahle E, Kornberg A. The partition locus of plasmid pSC101 is a specific binding site for DNA gyrase. EMBO J, 1988, 7(6): 1889-1895.
16. Miller CA, Beaucage SL, Cohen SN. Role of DNA superhelicity in partitioning of the pSC101 plasmid. Cell, 1990, 62(1): 127-133.
17. Meacock PA, Cohen SN. Partitioning of bacterial plasmids during cell division: a cis-acting locus that accomplishes stable plasmid inheritance. Cell, 1980, 20(2): 529-542.